Clinical Trial Update: Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Therapy for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (NeoHunter) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant therapy for ER+/HER2- breast cancer comparing High-Intensity Focused Ultrasound (HIFU) plus toripalimab and chemotherapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: ER+/HER2- Breast Cancer | Phase 2 | Status: RECRUITING